CLINICAL OUTCOME AND TOLERABILITY OF CONTROLLED RELEASE OXYBUTYNIN ON THE CATHETERIZATION OR VOIDING FREQUENCY IN MULTIPLE SCLEROSIS (MS) PATIENTS WITH NEUROGENIC BLADDER.
Tracy W. Cannon, Margie O'Leary, Janet R. Erickson, Christopher P. Smith, Steve Y. Chung, JiYoul Lee, Michael B. Chancellor
University of Pittsburgh Medical Center
|
|
Abstract 139
|
|
|
Non Discussion Poster
Scientific Non Discussion Poster Session 17
|
|
|